Medically reviewed by a licensed healthcare professional. Last updated March 2026.

Key Takeaways

  • Wegovy uses a 5-step dose escalation over 16 weeks before reaching the full 2.4 mg maintenance dose.
  • Most patients notice reduced appetite within the first 1 to 2 weeks, even at the lowest dose.
  • The STEP 1 trial showed 14.9% average body weight loss at 68 weeks, with most weight loss occurring in the first 6 to 9 months.
  • Approximately 83% of participants on Wegovy lost at least 5% of their body weight, and over one-third lost 20% or more.
  • Weight loss continues to improve as the dose increases, so early results do not reflect your full potential.

Wegovy's 5-Step Dose Escalation

Unlike some medications where you start at the full dose, Wegovy follows a carefully structured ramp-up. Each step lasts 4 weeks:

Step Weeks Weekly Dose
1 Weeks 1-4 0.25 mg
2 Weeks 5-8 0.5 mg
3 Weeks 9-12 1.0 mg
4 Weeks 13-16 1.7 mg
5 Week 17+ 2.4 mg (maintenance)

This 16-week ramp means you will not reach the full therapeutic dose until month 5 of treatment. That is important context for setting realistic expectations.

Month-by-Month Timeline

Month 1 (0.25 mg)

The first month is about tolerability, not results. The 0.25 mg dose is below the threshold for significant weight loss, but your body is already responding to semaglutide. Most people feel noticeably less hungry, particularly between meals. Food cravings, especially for high-calorie processed foods, often diminish during this period.

Typical weight loss in month 1: 2 to 4 pounds. Some patients lose more, some less. Do not judge the medication by this initial period.

Month 2 (0.5 mg)

At 0.5 mg, the weight loss signal strengthens. Appetite suppression becomes more pronounced, and many people find their portion sizes naturally shrink by 30 to 50%. The concept of "food noise," the persistent mental preoccupation with food, often fades dramatically at this dose.

Typical cumulative weight loss by end of month 2: 5 to 10 pounds.

Month 3 (1.0 mg)

The 1.0 mg dose is where things start to accelerate for many patients. This is the dose where the SUSTAIN trials (for diabetes) showed clinically meaningful effects. Weight loss becomes more consistent, and patients often settle into a pattern of losing 1 to 2 pounds per week.

Typical cumulative weight loss by end of month 3: 8 to 15 pounds.

Months 4-5 (1.7 mg, then 2.4 mg)

The final two escalation steps bring you to the full maintenance dose. By this point, semaglutide is working at maximum potency. Many patients report that 1.7 mg feels like a significant jump in appetite suppression compared to 1.0 mg.

Typical cumulative weight loss by end of month 5: 12 to 20 pounds.

Months 6-12 (2.4 mg maintenance)

This is the period of peak weight loss. According to the STEP 1 trial data, weight loss continues relatively steadily through months 6 to 9, then begins to decelerate. By month 12, most patients have achieved 80 to 90% of their total expected weight loss.

Typical cumulative weight loss at 12 months: 25 to 40 pounds (for someone starting at 220 lbs).

STEP 1 Trial Results by Timepoint

The STEP 1 trial enrolled 1,961 adults with BMI of 30+ (or 27+ with at least one weight-related condition) and tracked outcomes over 68 weeks:

  • Week 20: Average weight loss of approximately 10% in the semaglutide group vs. 2% placebo
  • Week 40: Average weight loss reached approximately 13%
  • Week 68: Average weight loss of 14.9% vs. 2.4% placebo

Additional outcome data from STEP 1:

  • 86.4% of semaglutide patients lost at least 5% of body weight (vs. 31.5% placebo)
  • 69.1% lost at least 10% (vs. 12.0% placebo)
  • 50.5% lost at least 15% (vs. 4.9% placebo)
  • 32.0% lost at least 20% (vs. 1.7% placebo)

These numbers are averages. Some patients do significantly better, and some respond less strongly.

Why Patience Matters with Wegovy

One of the biggest mistakes patients make is judging Wegovy too early. If you are 6 weeks in, losing only 3 pounds, and feeling discouraged, remember: you are not yet at a therapeutic dose. The medication is designed to work incrementally. Clinical trial data shows weight loss accelerating significantly between months 2 and 6.

Another common mistake is comparing your results to social media posts. People who lose 50+ pounds in 3 months are statistical outliers. The clinical trial average is closer to 1 pound per week at maintenance dose, which adds up to remarkable results over 12 to 18 months.

Maximizing Your Results on Wegovy

While Wegovy does the heavy lifting on appetite, your habits still matter:

  • Protein intake: Aim for 0.7 to 1.0 grams per pound of lean body mass. This preserves muscle during weight loss and keeps you feeling full.
  • Resistance training: Lifting weights 2 to 3 times per week helps prevent the muscle loss that can accompany any rapid weight loss.
  • Hydration: Semaglutide can cause dehydration, especially when combined with reduced food intake. Aim for 64+ ounces of water daily.
  • Sleep: Poor sleep increases ghrelin (hunger hormone) and can counteract semaglutide's appetite suppression.

Ready to start your weight loss journey? Find a GLP-1 clinic near you and connect with a qualified provider today.


Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.